[Effect of gliclazide on platelet behavior].
D000262:Adenylyl Cyclases / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002250:Carbon Radioisotopes; D003517:Cyclopentanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D010973:Platelet Adhesiveness / Q000187:drug effects; D011758:Pyrroles / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014316:Tritium; D014461:Ultracentrifugation
D001786:Blood Glucose; D002250:Carbon Radioisotopes; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D014316:Tritium; D000262:Adenylyl Cyclases
Effect du gliclazide sur le comportement plaquettaire